SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-015391
Filing Date
2020-01-27
Accepted
2020-01-27 16:23:08
Documents
8
Period of Report
2020-01-27
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d878707d8k.htm 8-K 22796
2 EX-5.1 d878707dex51.htm EX-5.1 10620
3 EX-99.1 d878707dex991.htm EX-99.1 11578
4 EX-99.2 d878707dex992.htm EX-99.2 16916
5 GRAPHIC g878707g0127093234902.jpg GRAPHIC 4602
6 GRAPHIC g878707g0127093235058.jpg GRAPHIC 8893
7 GRAPHIC g878707g0127093235199.jpg GRAPHIC 2617
8 GRAPHIC g878707g0127094052330.jpg GRAPHIC 2714
  Complete submission text file 0001193125-20-015391.txt   89695
Mailing Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9
Business Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9 (604) 678-1388
Zymeworks Inc. (Filer) CIK: 0001403752 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38068 | Film No.: 20549795
SIC: 2834 Pharmaceutical Preparations